Skip to content

S. 326 · 118th Congress (2023–2025)

VA Medicinal Cannabis Research Act of 2023

This bill requires the Department of Veterans Affairs (VA) to study the effects of cannabis on veterans who are enrolled in the VA health care system and have been diagnosed with post-traumatic stress disorder (PTSD) or chronic pain (i.e., eligible veterans).

First, the bill requires the VA to conduct an observational, 18-month study on the effects of cannabis on the health outcomes of eligible veterans. The VA must report on the study and address whether it is able to meet criteria necessary to conduct clinical trials.

Then, if the VA determines that it is able to proceed, it must carry out a series of clinical trials on the effects of cannabis appropriate for investigational use, as determined by the Food and Drug Administration, on the outcomes of eligible veterans. The VA must carry out a long-term observational study of the clinical trial participants.

The VA may terminate the trials if it is unable to meet clinical guideline requirements or the trials would create excessive risk to participants.

The VA must ensure that the study and trials are representative of the demographics of veterans in the United States, as determined by the most recent data from the American Community Survey of the Bureau of the Census.

The study and trials must include mechanisms to ensure data preservation and registration as necessary (in an anonymous form).

Show official title

A bill to direct the Secretary of Veterans Affairs to carry out a study and clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder, and for other purposes.

Failed cloture in Senate

Latest actionCloture rejected

This bill’s path

This is S. 326’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Jon Tester (D-MT)
Cosponsors
9 cosponsors

1 original · 8 later

2 R · 5 D · 2 I

  1. Sen. Dan Sullivan (R-AK)· Original · Feb 9, 2023
  2. Sen. Tammy Duckworth (D-IL)· Later · Mar 6, 2023
  3. Sen. John Fetterman (D-PA)· Later · Apr 25, 2023
  4. Sen. John W. Hickenlooper (D-CO)· Later · Apr 25, 2023
  5. Sen. Mark Kelly (D-AZ)· Later · Apr 25, 2023
  6. Sen. Angus S. King Jr. (I-ME)· Later · Apr 25, 2023
  7. Sen. Jacky Rosen (D-NV)· Later · Apr 25, 2023
  8. Sen. Kyrsten Sinema (I-AZ)· Later · Apr 25, 2023
  9. Sen. Todd Young (R-IN)· Later · Apr 25, 2023
Policy area
Armed Forces and National Security
Subjects
  • Alternative treatments
  • Congressional oversight
  • Drug trafficking and controlled substances
  • Government studies and investigations
  • Health information and medical records
  • Medical research
  • Mental health
  • Neurological disorders
  • 1 more
    • Veterans' medical care

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 5 actions · Feb 9, 2023 – Apr 26, 2023
    1. Referred to committee

      Read twice and referred to the Committee on Veterans' Affairs.

      Sources
    2. Ordered reported

      Committee on Veterans' Affairs. Ordered to be reported without amendment favorably.

      Sources
    3. Reported by committee

      Committee on Veterans' Affairs. Reported by Senator Tester without amendment. Without written report.

      Sources
    4. Cloture motion presented

      Congressional Record S1286

      Cloture motion on the motion to proceed to the measure presented in Senate.

      Sources
    5. Cloture rejected

      Roll call 97

      Cloture on the motion to proceed to the measure not invoked in Senate by Yea-Nay Vote. 57 - 42. Record Vote Number: 97.

      Sources

Roll-call votes

  1. Senate roll call 97Rejected

    On Cloture on the Motion to Proceed

    57–42

Committees

  1. SenateVeterans' AffairsReferred Feb 9, 2023 · Markup Feb 16, 2023 · Reported Mar 23, 2023
    1. Feb 16, 2023 · Meeting

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. VA Medicinal Cannabis Research Act of 2023

    Display title, Short title · Introduced in Senate, Reported to Senate

  2. A bill to direct the Secretary of Veterans Affairs to carry out a study and clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder, and for other purposes.

    Official title · Introduced in Senate